OpenAI product and business chief Fidji Simo said Thursday, July 9, 2026, that she is stepping down from her full-time role [1].
As the company's No. 2 executive [3], Simo's departure marks a significant leadership shift for the artificial-intelligence firm during a period of rapid global expansion.
Simo will transition to a part-time advisor role to focus on recovery from a chronic illness [1, 2, 4]. Reports indicate the decision follows a severe exacerbation of Postural Orthostatic Tachycardia Syndrome, known as POTS [2, 5].
Simo joined OpenAI in May 2025 [2]. During her tenure, she served as the product and business chief, though some reports also identify her as the CEO of AGI Deployment [1, 6].
The company announced the transition via a formal statement [1, 2]. While the exact timeline for her advisory capacity was not specified, the move allows her to prioritize her health while maintaining a connection to the organization's strategic goals [1, 4].
OpenAI has not yet named a permanent successor for her full-time responsibilities. The transition comes as the company continues to navigate the complex scaling of its AI products and business operations [1, 2].
“Fidji Simo is stepping down from her full-time role at OpenAI.”
The departure of a top-tier executive like Simo, described as the company's No. 2, creates a leadership vacuum in the product and business divisions of the world's most prominent AI lab. Because she is moving into an advisory role rather than leaving the company entirely, OpenAI retains her institutional knowledge while managing the operational risk of a sudden leadership transition.
